XML 69 R56.htm IDEA: XBRL DOCUMENT v3.21.2
Geneos Therapeutics, Inc. - Deconsolidation Accounting (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 01, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Noncontrolling Interest [Line Items]            
Fixed assets, net of accumulated depreciation   $ (18,111,288)   $ (18,111,288)   $ (11,348,144)
Gain on deconsolidation of Geneos   $ 0 $ (4,121,075) 0 $ (4,121,075)  
Decrease in cash resulting from the deconsolidation of Geneos       $ 0 $ 2,774,851  
Geneos Therapeutics, Inc.            
Noncontrolling Interest [Line Items]            
Working capital (excluding cash) $ (59,992)          
Note payable 171,620          
Fixed assets, net of accumulated depreciation (16,340)          
Carrying value of noncontrolling interest 3,181,640          
Fair value of investment in Geneos retained 3,618,998          
Gain on deconsolidation of Geneos (4,121,075)          
Decrease in cash resulting from the deconsolidation of Geneos $ 2,774,851